Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Limal

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|February 2, 2022
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?Pauline Morel, Alexandre Karras, Raphaël Porcher, et al.
Blood|June 30, 2016
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopeniaMatthieu Mahévas, Mathieu Gerfaud-Valentin, Guillaume Moulis, et al.
British Journal of Haematology|May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experienceEtienne Crickx, Mikael Ebbo, Etienne Rivière, et al.
British Journal of Haematology|April 6, 2019
Autologous<sup>111</sup> Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonistsMatthieu Mahevas, Sandrine Van Eeckhoudt, Guillaume Moulis, et al.
Rheumatology (Oxford, England)|January 11, 2022
Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 studyMaddalena Larosa, Véronique Le Guern, Gaëlle Guettrot-Imbert, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitidesBenjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Blood|May 24, 2015
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosisStéphane Barete, Olivier Lortholary, Gandhi Damaj, et al.
The New England Journal of Medicine|November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitisLoïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2025
ANCA-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap with Significant Implications for Treatment and OutcomesDeborah Eshagh, Thomas Quéméneur, Alexandre Karras, et al.
Blood|October 27, 2012
A case-control study to assess the risk of immune thrombocytopenia associated with vaccinesLamiae Grimaldi-Bensouda, Marc Michel, Elodie Aubrun, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|February 2, 2022
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?Pauline Morel, Alexandre Karras, Raphaël Porcher, et al.
Blood|June 30, 2016
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopeniaMatthieu Mahévas, Mathieu Gerfaud-Valentin, Guillaume Moulis, et al.
British Journal of Haematology|May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experienceEtienne Crickx, Mikael Ebbo, Etienne Rivière, et al.
British Journal of Haematology|April 6, 2019
Autologous<sup>111</sup> Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonistsMatthieu Mahevas, Sandrine Van Eeckhoudt, Guillaume Moulis, et al.
Rheumatology (Oxford, England)|January 11, 2022
Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 studyMaddalena Larosa, Véronique Le Guern, Gaëlle Guettrot-Imbert, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitidesBenjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Blood|May 24, 2015
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosisStéphane Barete, Olivier Lortholary, Gandhi Damaj, et al.
The New England Journal of Medicine|November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitisLoïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2025
ANCA-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap with Significant Implications for Treatment and OutcomesDeborah Eshagh, Thomas Quéméneur, Alexandre Karras, et al.
Blood|October 27, 2012
A case-control study to assess the risk of immune thrombocytopenia associated with vaccinesLamiae Grimaldi-Bensouda, Marc Michel, Elodie Aubrun, et al.
Pageof 8